THMO (ThermoGenesis Holdings, Inc.) רווחיות לפי רווח גולמי

ThermoGenesis develops automated cell separation systems and biobanking software, leveraging patented centrifuge technology. The gross margin fluctuations on this GURU.Markets chart show that the 21.10 level is the current value. The business relies on deep system integration within laboratories, which creates high switching costs for equipment. Low geopolitical risks and the humanitarian status of medicine ensure stable global distribution.
פילוחי מדדים פיננסיים ומדדי שוק עבור ThermoGenesis Holdings, Inc. (THMO)

ThermoGenesis (THMO) struggle for survival in the automated cell processing segment is directly reflected in its gross margin fluctuations. This indicator measures the portion of revenue remaining after deducting direct production costs, which determines the fundamental efficiency of the business model. Analyzing the spread between the selling price and the cost of goods sold allows investors to assess the company's ability to generate profit amid resource shortages.